SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: Don Hurst who wrote (1381)6/8/1999 11:56:00 AM
From: Walt  Respond to of 1510
 
Don:
You are correct on both counts. Margie did a super job explaining the results of the trial and IMNR's intentions to continue with Remune. The press release you posted is correct, the date of the release is April 15, 1999. You can obtain any and all of IMNR's releases going all the way back to 1/7/97. IMNR's web site is
imnr.com
There you will find 1-800-491-0153 to their fax system and instructions. This is one for the LONG term.

Walter



To: Don Hurst who wrote (1381)6/8/1999 1:30:00 PM
From: jake burns  Respond to of 1510
 
IMNR is working with world-renowned Dr. Keith Black on their brain Cancer therapy. There was a huge article on Dr. Black in Time magazine in Nov. 1997 I think. The issue focused on Medicine in general and profiled the leaders in various fields. The article on Black was called the Tumor War, and referenced IMNR's technology.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News